145 related articles for article (PubMed ID: 32051510)
1. A Targeted Quantitative Proteomic Method Revealed a Substantial Reprogramming of Kinome during Melanoma Metastasis.
Miao W; Li L; Liu X; Qi TF; Guo L; Huang M; Wang Y
Sci Rep; 2020 Feb; 10(1):2485. PubMed ID: 32051510
[TBL] [Abstract][Full Text] [Related]
2. A Targeted Proteomic Approach for Heat Shock Proteins Reveals DNAJB4 as a Suppressor for Melanoma Metastasis.
Miao W; Li L; Wang Y
Anal Chem; 2018 Jun; 90(11):6835-6842. PubMed ID: 29722524
[TBL] [Abstract][Full Text] [Related]
3. A Targeted Quantitative Proteomic Approach Assesses the Reprogramming of Small GTPases during Melanoma Metastasis.
Huang M; Qi TF; Li L; Zhang G; Wang Y
Cancer Res; 2018 Sep; 78(18):5431-5445. PubMed ID: 30072397
[TBL] [Abstract][Full Text] [Related]
4. Discovery of TBC1D7 as a Potential Driver for Melanoma Cell Invasion.
Qi TF; Guo L; Huang M; Li L; Miao W; Wang Y
Proteomics; 2020 Jul; 20(14):e1900347. PubMed ID: 32510182
[TBL] [Abstract][Full Text] [Related]
5. Targeted Quantitative Kinome Analysis Identifies PRPS2 as a Promoter for Colorectal Cancer Metastasis.
Miao W; Wang Y
J Proteome Res; 2019 May; 18(5):2279-2286. PubMed ID: 30908912
[TBL] [Abstract][Full Text] [Related]
6. SOX9 is a dose-dependent metastatic fate determinant in melanoma.
Yang X; Liang R; Liu C; Liu JA; Cheung MPL; Liu X; Man OY; Guan XY; Lung HL; Cheung M
J Exp Clin Cancer Res; 2019 Jan; 38(1):17. PubMed ID: 30642390
[TBL] [Abstract][Full Text] [Related]
7. Parallel-Reaction-Monitoring-Based Proteome-Wide Profiling of Differential Kinase Protein Expression during Prostate Cancer Metastasis in Vitro.
Miao W; Yuan J; Li L; Wang Y
Anal Chem; 2019 Aug; 91(15):9893-9900. PubMed ID: 31241916
[TBL] [Abstract][Full Text] [Related]
8. A targeted quantitative proteomics strategy for global kinome profiling of cancer cells and tissues.
Xiao Y; Guo L; Wang Y
Mol Cell Proteomics; 2014 Apr; 13(4):1065-75. PubMed ID: 24520089
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
[TBL] [Abstract][Full Text] [Related]
10. Targeted Quantitative Profiling of GTP-Binding Proteins Associated with Metastasis of Melanoma Cells.
Cai R; Bade D; Liu X; Huang M; Qi TF; Wang Y
J Proteome Res; 2021 Nov; 20(11):5189-5195. PubMed ID: 34694799
[TBL] [Abstract][Full Text] [Related]
11. Glypican 6 is a putative biomarker for metastatic progression of cutaneous melanoma.
Li Y; Li M; Shats I; Krahn JM; Flake GP; Umbach DM; Li X; Li L
PLoS One; 2019; 14(6):e0218067. PubMed ID: 31199813
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for EBF3 as a candidate epigenetic driver of melanoma metastasis.
Chatterjee A; Stockwell PA; Ahn A; Rodger EJ; Leichter AL; Eccles MR
Oncotarget; 2017 Jan; 8(4):6085-6101. PubMed ID: 28030832
[TBL] [Abstract][Full Text] [Related]
13. TGF-β signaling, activated stromal fibroblasts, and cysteine cathepsins B and L drive the invasive growth of human melanoma cells.
Yin M; Soikkeli J; Jahkola T; Virolainen S; Saksela O; Hölttä E
Am J Pathol; 2012 Dec; 181(6):2202-16. PubMed ID: 23063511
[TBL] [Abstract][Full Text] [Related]
14. EGF-induced MMP-9 expression is mediated by the JAK3/ERK pathway, but not by the JAK3/STAT-3 pathway in a SKBR3 breast cancer cell line.
Kim S; Choi JH; Lim HI; Lee SK; Kim WW; Cho S; Kim JS; Kim JH; Choe JH; Nam SJ; Lee JE; Yang JH
Cell Signal; 2009 Jun; 21(6):892-8. PubMed ID: 19385051
[TBL] [Abstract][Full Text] [Related]
15. Proteomic profiling of human melanoma metastatic cell line secretomes.
Rocco M; Malorni L; Cozzolino R; Palmieri G; Rozzo C; Manca A; Parente A; Chambery A
J Proteome Res; 2011 Oct; 10(10):4703-14. PubMed ID: 21815687
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases in human melanoma.
Hofmann UB; Westphal JR; Van Muijen GN; Ruiter DJ
J Invest Dermatol; 2000 Sep; 115(3):337-44. PubMed ID: 10951266
[TBL] [Abstract][Full Text] [Related]
17. mda-9/Syntenin regulates the metastatic phenotype in human melanoma cells by activating nuclear factor-kappaB.
Boukerche H; Su ZZ; Emdad L; Sarkar D; Fisher PB
Cancer Res; 2007 Feb; 67(4):1812-22. PubMed ID: 17308124
[TBL] [Abstract][Full Text] [Related]
18. Coexpression network analysis identified that plakophilin 1 is associated with the metastasis in human melanoma.
Wang HZ; Wang F; Chen PF; Zhang M; Yu MX; Wang HL; Zhao Q; Liu J
Biomed Pharmacother; 2019 Mar; 111():1234-1242. PubMed ID: 30841437
[TBL] [Abstract][Full Text] [Related]
19. Activation of Vav/Rho GTPase signaling by CXCL12 controls membrane-type matrix metalloproteinase-dependent melanoma cell invasion.
Bartolomé RA; Molina-Ortiz I; Samaniego R; Sánchez-Mateos P; Bustelo XR; Teixidó J
Cancer Res; 2006 Jan; 66(1):248-58. PubMed ID: 16397238
[TBL] [Abstract][Full Text] [Related]
20. A PGC1α-mediated transcriptional axis suppresses melanoma metastasis.
Luo C; Lim JH; Lee Y; Granter SR; Thomas A; Vazquez F; Widlund HR; Puigserver P
Nature; 2016 Sep; 537(7620):422-426. PubMed ID: 27580028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
